John Xu
Vorstandsvorsitzender bei Jemincare Therapeutics Corp.
Profil
John Xu is the founder and Chief Executive Officer of Jemincare Therapeutics Corp.
which is founded in 2018.
He was also a Senior Vice President of Strategic Alliances at Abpro Corp.
from 2017 to 2019.
Dr. Xu holds a doctorate from Zhongshan Hospital Fudan University, a graduate degree from Chicago Medical School, and an MBA from the University of Colorado Colorado Springs.
Aktive Positionen von John Xu
Unternehmen | Position | Beginn |
---|---|---|
Jemincare Therapeutics Corp.
Jemincare Therapeutics Corp. BiotechnologyHealth Technology Jemincare Therapeutics Corp. is a pharmaceutical company. It plans to in license the global and China rights of the large and small molecule clinical stage programs in therapeutic areas such as oncology, cardiovascular and kidney disease. The company was founded by John Xu in November 2018 and is headquartered in Princeton, NJ. | Vorstandsvorsitzender | 01.11.2018 |
Ehemalige bekannte Positionen von John Xu
Unternehmen | Position | Ende |
---|---|---|
ABPRO CORPORATION | Corporate Officer/Principal | - |
Ausbildung von John Xu
Zhongshan Hospital Fudan University | Doctorate Degree |
University of Colorado Colorado Springs | Masters Business Admin |
Chicago Medical School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Abpro Corp.
Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA. | Health Technology |
Jemincare Therapeutics Corp.
Jemincare Therapeutics Corp. BiotechnologyHealth Technology Jemincare Therapeutics Corp. is a pharmaceutical company. It plans to in license the global and China rights of the large and small molecule clinical stage programs in therapeutic areas such as oncology, cardiovascular and kidney disease. The company was founded by John Xu in November 2018 and is headquartered in Princeton, NJ. | Health Technology |